DNA variants in DHFR gene and response to treatment in children with childhood B ALL: revisited in AIEOP-BFM protocol

Dihydrofolate Reductase Genetic Polymorphisms Affect Methotrexate Dose Requirements in Pediatric Patients With Acute Lymphoblastic Leukemia on Maintenance Therapy

(2017) Guillermo Gervasini et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000

(2016) A. Moricke et al.   BLOOD

Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children’s Oncology Group Study AALL0232

(2016) Eric C. Larsen et al.   JOURNAL OF CLINICAL ONCOLOGY

Influence of dihydrofolate reductase gene polymorphisms rs408626 (-317A>G) and rs442767 (-680C>A) on the outcome of methotrexate-based maintenance therapy in South Indian patients with acute lymphoblastic leukemia

(2015) Sunitha Kodidela et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Childhood high-risk acute lymphoblastic leukemia in first remission: results after chemotherapy or transplant from the AIEOP ALL 2000 study

(2014) V. Conter et al.   BLOOD

Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process

(2014) Kelly Caudle et al.   CURRENT DRUG METABOLISM

Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing: 2013 Update

(2013) M V Relling et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Acute lymphoblastic leukaemia

(2013) Hiroto Inaba et al.   LANCET

Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia

(2012) J. J. Yang et al.   BLOOD

Survival and risk of relapse of acute lymphoblastic leukemia in a Mexican population is affected by dihydrofolate reductase gene polymorphisms

(2012) YAZMÍN GÓMEZ-GÓMEZ et al.   Experimental and Therapeutic Medicine

ATF5 polymorphisms influence ATF function and response to treatment in children with childhood acute lymphoblastic leukemia

(2011) J. Rousseau et al.   BLOOD

Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study

(2011) M. Schrappe et al.   BLOOD

Methotrexate consolidation treatment according to pharmacogenetics of MTHFR ameliorates event-free survival in childhood acute lymphoblastic leukaemia

(2011) J Salazar et al.   PHARMACOGENOMICS JOURNAL

Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study

(2010) V. Conter et al.   BLOOD

Polymorphisms in multidrug resistance-associated protein gene 4 is associated with outcome in childhood acute lymphoblastic leukemia

(2009) M. Ansari et al.   BLOOD

DNA Variants in Region for Noncoding Interfering Transcript of Dihydrofolate Reductase Gene and Outcome in Childhood Acute Lymphoblastic Leukemia

(2009) F. Al-Shakfa et al.   CLINICAL CANCER RESEARCH

Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival

(2009) A. Ongaro et al.   HAEMATOLOGICA

DNA variants in the dihydrofolate reductase gene and outcome in childhood ALL

(2007) S. Dulucq et al.   BLOOD